Predicting & Selecting Promising Drug Compounds
BIOL-40219
Learn the process and considerations in predicting and selecting the most promising alternative among various candidate drug compounds. In a very practical way, this course applies the principles taught in previous courses related to the likelihood of positive absorption, distribution, metabolism, excretion and toxicology/patient safety outcomes of each compound. This course will include the use of in vitro studies utilized to predict in vivo outcomes in both test animals and humans
Course Information
Course sessions
Section ID:
Class type:
This course is entirely web-based and to be completed asynchronously between the published course start and end dates. Synchronous attendance is NOT required.
You will have access to your online course on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.
Textbooks:
No textbook required.
Policies:
- No refunds after: 1/20/2025
Schedule:
Instructor:
Ajay Madan, Ph.D., DABT
Vice President, Preclinical Development, Neurocrine Biosciences
Ajay Madan is senior director of preclinical development at Neurocrine. He has worked with pharmaceutical companies in characterization and risk assessment of metabolism liabilities of new chemical entities. He has 13+ years of industry experience with in vitro drug metabolism, pharmacokinetics and toxicology.
